(Q35600432)

9 August 2017

1 reference

title

Hyperhomocysteinemia and immune activation (English)

1 reference

9 August 2017

4

Friedrich Leblhuber

1 reference

9 August 2017

6

Dietmar Fuchs

1 reference

9 August 2017

Katharina Schroecksnadel

series ordinal

1

object named as

Katharina Schroecksnadel

1 reference

9 August 2017

Barbara Frick

2

1 reference

9 August 2017

Christiana Winkler

series ordinal

3

1 reference

9 August 2017

Barbara Wirleitner

series ordinal

5

1 reference

9 August 2017

1 November 2003

1 reference

Clinical Chemistry and Laboratory Medicine

9 August 2017

1 reference

9 August 2017

41

1 reference

9 August 2017

11

1 reference

9 August 2017

1438-1443

1 reference

The importance of hyperhomocysteinemia as a risk factor for diseases: an overview

9 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Serum folate and homocysteine levels in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Inflammation and Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Is hyperhomocysteinemia due to the oxidative depletion of folate rather than to insufficient dietary intake?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Oxidative DNA damage and cellular sensitivity to oxidative stress in human autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Moderate hyperhomocysteinaemia and immune activation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Hyperhomocysteinemia in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Hyperhomocysteinemia, pteridines and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Smoking and plasma homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

The impact of vegetarianism on some haematological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.221

21 January 2018

Identifiers

DOI

10.1515/CCLM.2003.221

1 reference

9 August 2017

1 reference